These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 12569967)

  • 21. [The efficacy of botulinum toxin therapy in patients with upper limb spasticity due to traumatic brain injury].
    Akulov MA; Hat'kova SE; Mokienko OA; Orlova OR; Usachev DY; Zakharov VO; Orlova AS; Tomskiy AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(8):30-35. PubMed ID: 27635608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local botulinum toxin type A injections in the treatment of spastic toes.
    Suputtitada A
    Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
    Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
    NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations.
    Borg-Stein J; Pine ZM; Miller JR; Brin MF
    Am J Phys Med Rehabil; 1993 Dec; 72(6):364-8. PubMed ID: 8260129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC; Lin IL; Chou TF; Lee HM
    J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum Toxin: From Poison to Possible Treatment for Spasticity in Spinal Cord Injury.
    Palazón-García R; Benavente-Valdepeñas AM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of botulinum toxin injections in the upper limbs of children with cerebral palsy: A systematic review of the literature.
    Klein C; Gouron R; Barbier V
    Orthop Traumatol Surg Res; 2024 May; 110(3):103578. PubMed ID: 36754169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of NT 201 for upper limb spasticity of various etiologies--a randomized parallel-group study.
    Barnes M; Schnitzler A; Medeiros L; Aguilar M; Lehnert-Batar A; Minnasch P
    Acta Neurol Scand; 2010 Oct; 122(4):295-302. PubMed ID: 20456248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Open-label study of botulinum toxin for upper limb spasticity in cerebral palsy.
    Wong V; Ng A; Sit P
    J Child Neurol; 2002 Feb; 17(2):138-42. PubMed ID: 11952075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
    Olvey EL; Armstrong EP; Grizzle AJ
    Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin: dosing and dilution.
    Francisco GE
    Am J Phys Med Rehabil; 2004 Oct; 83(10 Suppl):S30-7. PubMed ID: 15448575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common Etiologies of Upper Extremity Spasticity.
    Angulo-Parker FJ; Adkinson JM
    Hand Clin; 2018 Nov; 34(4):437-443. PubMed ID: 30286958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin for spasticity and athetosis in children with cerebral palsy.
    Gooch JL; Sandell TV
    Arch Phys Med Rehabil; 1996 May; 77(5):508-11. PubMed ID: 8629930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
    Dong Y; Wu T; Hu X; Wang T
    Eur J Phys Rehabil Med; 2017 Apr; 53(2):256-267. PubMed ID: 27834471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity.
    De Icco R; Perrotta A; Berra E; Allena M; Alfonsi E; Tamburin S; Serrao M; Sandrini G; Tassorelli C
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31226803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.